Valuation: Proteome Sciences plc

Market Cap 5.12M 6.85M 6.13M 5.66M 9.58M 652M 9.73M 67.51M 26.93M 341M 25.7M 25.15M 1.08B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.11M 26.89M 24.09M 22.22M 37.6M 2.56B 38.21M 265M 106M 1.34B 101M 98.78M 4.24B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day+4.29%
1 week+8.55%
Current month+0.34%
1 month+0.34%
3 months-18.89%
6 months+3.18%
Current year-41.60%
1 week 1.21
Extreme 1.21
1.69
1 month 1.2
Extreme 1.2
1.7
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
6.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
10
Manager TitleAgeSince
Corporate Officer/Principal - 31/03/2017
Corporate Secretary - 31/07/2017
Director TitleAgeSince
Chairman 73 29/06/2014
Director/Board Member 62 31/12/2009
Director/Board Member 64 15/10/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
+4.29%+8.55%-27.00%-76.92% 6.85M
+1.88%+2.01%-15.96%+12.62% 181B
+2.55%+1.52%-15.65%+19.03% 120B
+2.46%+0.54%+5.87%+39.87% 119B
+0.31%-1.27%-44.01%+6.31% 91.44B
+1.91%-2.35%-0.79%+76.15% 63.07B
-0.46%+0.42%+8.19%+82.97% 55.8B
+1.63%-1.04%+9.27%-21.17% 54.03B
+2.32%+1.63%-8.23%+47.17% 45.38B
+0.54%+1.76%-1.31%-6.65% 34.37B
Average +1.51%+1.29%-8.96%+17.94% 76.35B
Weighted average by Cap. +1.30%+0.76%-9.95%+26.30%

Financials

2024 2025
Net sales 4.89M 6.54M 5.85M 5.4M 9.14M 622M 9.29M 64.43M 25.7M 326M 24.53M 24M 1.03B 3.76M 5.02M 4.5M 4.15M 7.02M 478M 7.14M 49.52M 19.75M 250M 18.85M 18.45M 793M
Net income -3.41M -4.55M -4.08M -3.76M -6.37M -434M -6.47M -44.9M -17.91M -227M -17.09M -16.73M -719M -3.06M -4.09M -3.67M -3.38M -5.72M -390M -5.82M -40.36M -16.1M -204M -15.36M -15.04M -646M
Net Debt 13.39M 17.91M 16.04M 14.8M 25.05M 1.71B 25.45M 177M 70.45M 893M 67.22M 65.79M 2.83B 14.99M 20.04M 17.95M 16.56M 28.03M 1.91B 28.48M 198M 78.84M 999M 75.23M 73.62M 3.16B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
29/10/26 GBX 1.460 +4.29% 270,196
28/10/26 GBX 1.400 -3.45% 1,338
27/10/26 GBX 1.450 0.00% 80,973
26/10/26 GBX 1.450 +7.81% 9,133
23/10/26 GBX 1.345 0.00% 20,585